ArticlePLoS neglected tropical diseases2026
How rash and eschar came to clinical attention in scrub typhus and Japanese spotted fever.
Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEarly diagnosis of scrub typhus and Japanese spotted fever remains challenging because initial manifestations are often nonspecific. In endemic areas, nearly 30% of patients were not correctly diagnosed at the first visit to a participating site. Previous studies have mainly treated rash and eschar as present-or-absent findings. We examined how rash and eschar came to clinical attention in patients correctly diagnosed at the first visit to a participating site and in those diagnosed later. METHODOLOGY/PRINCIPAL
findingsWe analyzed 217 patients with scrub typhus or Japanese spotted fever from three healthcare facilities in an endemic region of Japan. Because first-visit documentation was incomplete in many delayed-diagnosis cases, recognition-pattern variables were abstracted at the time the correct diagnosis was established. Among these patients, 156 (71.9%) were correctly diagnosed at the first visit to a participating site and 61 (28.1%) were diagnosed after one or more subsequent visits. In multivariable analysis, correct first-visit diagnosis was associated with rash reported as a chief complaint (adjusted odds ratio [aOR] 4.95, 95% confidence interval [CI] 2.07-11.84), rash elicited during history taking (aOR 5.86, 95% CI 2.80-12.27), eschar identified on physical examination (aOR 2.80, 95% CI 1.19-6.58), and eschar elicited during history taking, which was exclusively observed among patients diagnosed at the first visit to a participating site. Age 75 years or older was associated with lower odds of correct first-visit diagnosis (aOR 0.40, 95% CI 0.21-0.75). CONCLUSIONS/SIGNIFICANCE: In endemic settings, patients correctly diagnosed at the first visit to a participating site more often had rash and eschar brought to clinical attention in specific ways. Directed inquiry about skin symptoms and careful examination for eschar may help recognition in routine care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.